Skip to main content

Sana Biotechnology

Seattle, United States

Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.

$69.0M raised
May 2026
Post-IPO Equity

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Sana Biotechnology

How much funding has Sana Biotechnology raised?
Sana Biotechnology has raised $69.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2026.
Who are Sana Biotechnology's investors?
Sana Biotechnology's investors include RA Capital Management, ARCH Venture Partners, Mayo Clinic, Omega Funds, Google Ventures.
Where is Sana Biotechnology headquartered?
Sana Biotechnology is headquartered in Seattle, United States.
What does Sana Biotechnology do?
Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.
What stage is Sana Biotechnology at?
Sana Biotechnology is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Sana Biotechnology — Funding & Investors." VCBacked, May 15, 2026, https://www.vcbacked.co/company/sana-biotechnology. Accessed July 2, 2026.
APA
VCBacked. (2026). Sana Biotechnology — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/sana-biotechnology
Wikipedia (cite web)
{{cite web |title=Sana Biotechnology — Funding & Investors |url=https://www.vcbacked.co/company/sana-biotechnology |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .